C. Jemma

发表

Isolation of interferon-resistant variants of Friend erythroleukemia cells: effects of interferon and ouabain.

G. B. Rossi, E. Affabris, C. Jemma, 1982, Virology.

In situ hybridization evidence of the donor origin of a post‐transplant lymphoproliferative disorder

G. Palestro, G. Valente, S. Kerim, 1999, European journal of haematology.

A new childhood T-cell lymphoma established in nude mice and in vitro.

A. Modesti, M. G. Martinotti, L. C. di Montezemolo, 1988, Cancer Research.

Genome-Wide Meta-analysis identifies three novel loci associated with stroke: MEGASTROKE and UK Biobank GWAS

C. Sudlow, S. Debette, R. Malik, 2018 .

Injections of Interleukins Around Tumor-Draining Lymph Nodes: A New Mode of Immunotherapy

P. Musiani, G. Forni, D. Boraschi, 1989 .

Human herpesvirus 6 and Epstein-Barr virus in Hodgkin's disease: a controlled study by polymerase chain reaction and in situ hybridization.

P. Secchiero, G. Palestro, R. Gallo, 1996, The American journal of pathology.

Interleukin‐2 injected around tumor‐draining lymph nodes in head and neck cancer

G. Forni, S. Vai, A. De Stefani, 1991, Head & neck.

Treatment of recurrent squamous cell carcinoma of the head and neck with low doses of lnterleukin‐2 injected periiymphatically

G. Forni, A. De Stefani, M. Giovarelli, 1988, Cancer.

Helper strategy in tumor immunology: Expansion of helper lymphocytes and utilization of helper lymphokines for experimental and clinical immunotherapy

G. Forni, H. Fujiwara, T. Hamaoka, 1988, Cancer and Metastasis Reviews.

Functional properties in Sézary cells with an unusual phenotype.

M. Bernengo, F. Lisa, M. Meregalli, 1985, Clinical immunology and immunopathology.

HumanHerpesvirus 6andEpstein-Barr Virus in Hodgkin's Disease

G. Palestro, S. Kerim, C. Jemma, 1996 .

Tumor Immunotherapy with Combined Interleukins Injected Perilymphatically: Experimental and Clinical Findings

G. Forni, S. Vai, T. Musso, 1992 .

Interferon‐γ is not an antiviral, but a growth‐promoting factor for t lymphocytes

S. Landolfo, G. Gribaudo, M. Gariglio, 1988 .

In vitro and in vivo immunomodulatory activity of an N-9 arginyl hypoxanthine derivative (PCF-39).

P. Cornaglia-Ferraris, G. Forni, M. Giovarelli, 1987, International journal of immunopharmacology.

2-5A synthetase activity does not increase in interferon-resistant Friend leukemia cell variants treated with alpha/beta interferon despite the presence of high-affinity interferon receptor sites.

F. Belardelli, I. Gresser, N. Mechti, 1983, Virology.

Exome Aggregation Consortium

Adam Kiezun, Sergio Islas-Andrade, Pierre Fontanillas, 2016 .

Expanded HIV-1 cellular tropism by phenotypic mixing with murine endogenous retroviruses.

R. Gallo, B. Ensoli, P. Lusso, 1990, Science.

Obligatory role of IFN-gamma in induction of lymphokine-activated and T lymphocyte killer activity, but not in boosting of natural cytotoxicity.

G. Forni, A. Santoni, S. Landolfo, 1988, Journal of immunology.

released IL 2 is absorbed by the neoplastic B cell population from patients with B-chronic lymphocytic leukemia: evidence that normally Interleukin 2 (IL 2) and interferon-gamma production by T lymphocytes

R. Foà, G. Forni, P. Lusso, 2013 .

Interleukin 2 (IL 2) and interferon-gamma production by T lymphocytes from patients with B-chronic lymphocytic leukemia: evidence that normally released IL 2 is absorbed by the neoplastic B cell population

R. Foà, G. Forni, P. Lusso, 1985 .

R. Foà, G. Forni, P. Lusso, 1985, Blood.

Temporary regression of recurrent squamous cell carcinoma of the head and neck is achieved with a low but not with a high dose of recombinant interleukin 2 injected perilymphatically.

G. Forni, G. Margarino, G. Cortesina, 1994, British Journal of Cancer.

The effect of preoperative local interleukin-2 (IL-2) injections in patients with head and neck squamous cell carcinoma. An immunological study.

G. Forni, S. Vai, M. Bussi, 1991, Acta oto-laryngologica.

Xenotransplantation in immunosuppressed nude mice of human solid tumors and acute leukemias directly from patients orin vitro cell lines

R. Foà, M. Ferrarini, G. Forni, 1989, La Ricerca in clinica e in laboratorio.

Lymphokine-activated tumor inhibition in mice. Ability of a nonapeptide of the human IL-1 beta to recruit anti-tumor reactivity in recipient mice.

G. Forni, D. Boraschi, A. Tagliabue, 1989, Journal of immunology.

Interferon-gamma is not an antiviral, but a growth-promoting factor for T lymphocytes.

S. Landolfo, G. Gribaudo, M. Gariglio, 1988, European journal of immunology.

Infiltrating leukocyte populations and T-lymphocyte subsets in head and neck squamous cell carcinomas from patients receiving perilymphatic injections of recombinant interleukin 2. A pathologic and immunophenotypic study.

G. Forni, G. Palestro, M. Giovarelli, 1990, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

Effect of low doses of interleukin-2 injected perilymphatically and peritumorally in patients with advanced primary head and neck squamous cell carcinoma.

P. Musiani, G. Forni, S. Valitutti, 1989, Journal of biological response modifiers.

Tumor immunotherapy by local injection of interleukin 2 and non-reactive lymphocytes. Experimental and clinical results.

G. Forni, A. Santoni, A. Modesti, 1988, Progress in experimental tumor research.

Establishment of the antiviral state in alpha, beta-interferon-resistant Friend cells treated with gamma-interferon. Induction of 67-kilodalton protein kinase activity in absence of detectable 2-5A synthetase.

E. Coccia, N. Mechti, G. B. Rossi, 1985, The Journal of biological chemistry.

Treatment of recurrent squamous cell carcinoma of the head and neck with low doses of lnterleukin‐2 injected periiymphatically

G. Forni, M. Giovarelli, G. Cortesina, 1988, Cancer.

Serial Transplantation of a Human Acute T Lymphoblastic Leukemia into Nude Mice

G. Forni, M. G. Martinotti, R. Foa, 1986, Tumori.